3Sbio Inc. (SSRS) SEC Filing 20-F Annual report for the fiscal year ending Friday, December 31, 2010

3Sbio Inc.

CIK: 1383790 Ticker: SSRS

View differences made from one year to another to evaluate 3Sbio Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by 3Sbio Inc..


Assess how 3Sbio Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

3Sbio Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2011 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: SSRS
CIK: 1383790
Form Type: 20-F Annual Report
Accession Number: 0001104659-11-032999
Submitted to the SEC: Fri Jun 03 2011 6:02:47 AM EST
Accepted by the SEC: Fri Jun 03 2011
Period: Friday, December 31, 2010
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: